Brain PET scan imaging study for tumor diagnosis and monitoring
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how well a specific PET scan (using a tracer called [18F]FET) can help doctors diagnose brain tumors, check how well treatment is working, or spot tumors that come back. Researchers will analyze images you may have already had or will have as part of your regular care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had or will have a brain PET scan with [18F]FET as part of your medical care
- Your scan was ordered because of a suspected or known brain tumor (either starting in the brain or spread from elsewhere)
- Both still images and video-like images from your PET scan are available for study
- You are not pregnant or breastfeeding
- You are willing to sign a consent form allowing your scan images to be used for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This study uses a special PET/MRI scan with an amino acid tracer to better see if brain tumors (either starting in the brain or spreading from elsewhere) have come back after treatment. The scan may help doctors tell the difference between tumor growth and treatment-related changes.
This study uses a special type of brain scan (PET imaging) to better understand how cancer that has spread to the brain responds to radiation treatment. The scan may help doctors see which patients are responding well to treatment.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
Hear when a new Brain Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.